Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence.
Castro-Balado A, Cuartero-Martínez A, Pena-Verdeal H, Hermelo-Vidal G, Schmidt A, Montero B, Hernández-Blanco M, Zarra-Ferro I, González-Barcia M, Mondelo-García C, Giráldez MJ, Yebra-Pimentel E, Otero-Espinar FJ, Fernández-Ferreiro A.
Castro-Balado A, et al. Among authors: montero b.
Pharmaceutics. 2023 Nov 5;15(11):2589. doi: 10.3390/pharmaceutics15112589.
Pharmaceutics. 2023.
PMID: 38004568
Free PMC article.